Impact of Skin Type on Wonud Healing and Scarring Following Facial Skin Surgery

Inclusion Criteria: * Aged between 14 and 60 years. * Clinically and postoperatively pathologically diagnosed with a facial benign tumor (e.g., melanocytic nevus, sebaceous cyst, seborrheic keratosis, etc.) and having undergone standard surgical treatment. * Voluntary participation in this study with written informed consent obtained. * Commitment to comply with all study protocols and to complete all follow-up visits and data collection procedures. Exclusion Criteria: * Clinically or postoperatively diagnosed with a facial malignant tumor. * Wounds requiring staged excision or planned for secondary intention healing. * Surgical site located on or adjacent to the mucosal surface. * Known history of allergy to any medications or dressings to be used during or after surgery. * Presence of systemic diseases that significantly impair wound healing (e.g., poorly controlled diabetes, immunodeficiency disorders, active infections). * Current use of medications affecting wound healing or scar formation (e.g., long-term systemic corticosteroids, immunosuppressants). * Pregnancy or lactation. * Refusal to provide written informed consent, or anticipated inability to comply with study follow-up and data collection. * Concurrent participation in another interventional clinical trial. * Any other condition deemed by the investigator as likely to interfere with study results or increase participant risk.